KBC Group’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,439
Closed -$41K 1846
2024
Q2
$41K Hold
1,439
﹤0.01% 1718
2024
Q1
$42K Hold
1,439
﹤0.01% 1643
2023
Q4
$49K Hold
1,439
﹤0.01% 1548
2023
Q3
$44K Sell
1,439
-2,226
-61% -$68.1K ﹤0.01% 1555
2023
Q2
$147K Sell
3,665
-187
-5% -$7.5K ﹤0.01% 1047
2023
Q1
$157K Hold
3,852
﹤0.01% 1055
2022
Q4
$149K Hold
3,852
﹤0.01% 1070
2022
Q3
$205K Hold
3,852
﹤0.01% 958
2022
Q2
$225K Buy
3,852
+2,235
+138% +$131K ﹤0.01% 951
2022
Q1
$123K Hold
1,617
﹤0.01% 1131
2021
Q4
$97K Hold
1,617
﹤0.01% 1184
2021
Q3
$91K Sell
1,617
-1,617
-50% -$91K ﹤0.01% 1182
2021
Q2
$196K Hold
3,234
﹤0.01% 1175
2021
Q1
$226K Hold
3,234
﹤0.01% 1164
2020
Q4
$1.07M Hold
3,234
﹤0.01% 1138
2020
Q3
$194K Buy
+3,234
New +$194K ﹤0.01% 1122
2017
Q1
Sell
-2,201
Closed -$71K 1321
2016
Q4
$71K Sell
2,201
-43,454
-95% -$1.4M ﹤0.01% 1269
2016
Q3
$1.56M Buy
45,655
+45,144
+8,834% +$1.54M 0.02% 634
2016
Q2
$17K Sell
511
-11,025
-96% -$367K ﹤0.01% 1258
2016
Q1
$611K Sell
11,536
-16,488
-59% -$873K 0.01% 786
2015
Q4
$2.15M Buy
28,024
+27,018
+2,686% +$2.07M 0.04% 453
2015
Q3
$41K Sell
1,006
-2,021
-67% -$82.4K ﹤0.01% 1252
2015
Q2
$214K Sell
3,027
-39,302
-93% -$2.78M ﹤0.01% 1112
2015
Q1
$3.76M Buy
42,329
+14,159
+50% +$1.26M 0.05% 376
2014
Q4
$2.5M Buy
28,170
+20,936
+289% +$1.86M 0.03% 527
2014
Q3
$701K Sell
7,234
-39,512
-85% -$3.83M 0.02% 643
2014
Q2
$4.29M Buy
46,746
+11,726
+33% +$1.08M 0.05% 412
2014
Q1
$2.45M Buy
+35,020
New +$2.45M 0.04% 444